These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection. Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386 [TBL] [Abstract][Full Text] [Related]
3. The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model. Uwaydat S; Jha P; Tytarenko R; Brown H; Wiggins M; Bora PS; Bora NS Curr Eye Res; 2011 Sep; 36(9):787-96. PubMed ID: 21812661 [TBL] [Abstract][Full Text] [Related]
4. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection. Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480 [TBL] [Abstract][Full Text] [Related]
5. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation. Kernacki KA; Barrett R; Hazlett LD Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939 [TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats. Kim EC; Lee WS; Kim MS Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4569-73. PubMed ID: 20393106 [TBL] [Abstract][Full Text] [Related]
8. VIP and growth factors in the infected cornea. Jiang X; McClellan SA; Barrett RP; Berger EA; Zhang Y; Hazlett LD Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6154-61. PubMed ID: 21666233 [TBL] [Abstract][Full Text] [Related]
9. Intercellular adhesion molecule-2 (ICAM-2) and Pseudomonas aeruginosa ocular infection. Hobden JA DNA Cell Biol; 2003 Oct; 22(10):649-55. PubMed ID: 14611686 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882 [TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis. Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951 [TBL] [Abstract][Full Text] [Related]
13. Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis. Karicherla P; Hobden JA Curr Eye Res; 2010 Mar; 35(3):220-4. PubMed ID: 20373880 [TBL] [Abstract][Full Text] [Related]
15. Impact of topical corticosteroid pretreatment on susceptibility of the injured murine cornea to Pseudomonas aeruginosa colonization and infection. Wu YT; Truong TN; Tam C; Mendoza MN; Zhu L; Evans DJ; Fleiszig SMJ Exp Eye Res; 2019 Feb; 179():1-7. PubMed ID: 30343040 [TBL] [Abstract][Full Text] [Related]
16. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Lee EJ; Evans DJ; Fleiszig SM Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5220-7. PubMed ID: 14638720 [TBL] [Abstract][Full Text] [Related]
17. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis. Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931 [TBL] [Abstract][Full Text] [Related]